Adjunctive Tongxinluo Therapy Aids STEMI Outcomes
THURSDAY, Oct. 26, 2023-- In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy to guideline-directed treatment, is associated with significantly improved...
Read more »